0001415889-21-000526.txt : 20210203
0001415889-21-000526.hdr.sgml : 20210203
20210203191044
ACCESSION NUMBER: 0001415889-21-000526
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN HUBERT L
CENTRAL INDEX KEY: 0001565916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 21588045
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD, AP6C-1N
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02032021_040226.xml
X0306
4
2021-02-01
0000001800
ABBOTT LABORATORIES
ABT
0001565916
ALLEN HUBERT L
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
EXECUTIVE VICE PRESIDENT
Common shares without par value
2021-02-01
4
M
0
107793
39.12
A
259689
D
Common shares without par value
2021-02-01
4
M
0
95600
38.40
A
355289
D
Common shares without par value
2021-02-01
4
S
0
201343
123.4659
D
153946
D
Common shares without par value
2021-02-01
4
S
0
2050
124.0278
D
151896
D
Option (right to buy)
39.12
2021-02-01
4
M
0
107793
0
D
2017-02-21
2024-02-20
Common Shares
107793
0
D
Option (right to buy)
38.40
2021-02-01
4
M
0
95600
0
D
2019-02-19
2026-02-18
Common Shares
95600
189788
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 to $123.99, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 to $124.19, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
/s/ Hubert L. Allen by Jessica H. Paik, Attorney-in-Fact
2021-02-03